MGI Tech Unveils Cutting-Edge Multi-Omics Solutions at ESHG 2025

MGI Tech Revolutionizes Multi-Omics Solutions at ESHG 2025

At the forefront of genomic innovation, MGI Tech Co., Ltd. took center stage at the European Society of Human Genetics (ESHG) 2025 conference in Milan, showcasing their latest advancements in multi-omics technologies. With the reveal of their state-of-the-art mid-throughput sequencer DNBSEQ-T1+ and the groundbreaking single-cell library preparation workstation DNBelab C-YellowR 16, MGI is setting new standards for precision and efficiency in omics research.

Game-Changing Innovations in Sequencing and Automation

The highlight of MGI’s presentation was the DNBelab C-YellowR 16, which made its global debut at the conference. This machine allows researchers to process up to 16 single-cell samples simultaneously, reducing hands-on time by a staggering 90%. With high reproducibility and precision, this innovation addresses common challenges in manual single-cell operations such as complexity, throughput limitations, and data variability.

What sets the DNBelab C-YellowR 16 apart is its fully automated workflow that operates with minimal human intervention. Integrated functional modules streamline the entire process—from cell and nucleus suspension to output of DNA nanoballs (DNBs) ready for sequencing. The machine handles everything from pipetting to library preparation and quality control, allowing researchers to focus on analysis rather than manual tasks.

A Leap Forward for Transcriptome Applications

In addition to the sequencing innovations, MGI has developed a highly sensitive full-length transcriptome library preparation solution. This new technology enables transcriptome profiling from as little as 10 picograms of RNA or merely 10 cells, making it an ideal choice for researchers dealing with limited or challenging samples.

According to Dr. Christian Zimmerman, VP of Sales for Europe & Africa at MGI, the response to their innovations at ESHG was overwhelmingly positive, highlighting the growing excitement for integrated multi-omics workflows. “We are thrilled to present our latest innovations at ESHG, a pivotal gathering for Europe’s genomics community,” Dr. Zimmerman stated, emphasizing the importance of these technologies in creating strong connections with researchers and clinical laboratories alike.

Streamlined Workflow and Automation for Genomic Research

The DNBelab C-YellowR 16's design is focused on delivering scalable, walkaway automation in single-cell genomics, making it a crucial asset for modern research laboratories. Researchers at the conference were drawn in by live demonstrations of the system, which showcased the potential for optimized workflow efficiency through automation.

MGI’s extensive sequencing portfolio also received attention during the exhibition, featuring a range from benchtop to ultra-high-throughput platforms. Among these, the DNBSEQ-T1+ was first introduced at AGBT 2025, emphasizing MGI’s commitment to innovation and excellence.

Implication for Future Research and Clinical Applications

The implications of MGI's displays at ESHG 2025 stretch beyond mere laboratory efficiency. As biotechnological advancements continue to evolve, the ability to perform high-quality sequencing and analysis from limited samples will significantly impact personalized medicine, genomics research, and clinical applications. By facilitating faster and more accurate results, MGI's technologies can pave the way for breakthroughs in understanding genetic conditions and enhancing disease diagnosis.

Conclusion: Preparing for a Genomic Future

As MGI Tech continues to push the boundaries of genomics and multi-omics solutions, their latest innovations present exciting new opportunities for researchers and clinicians alike. Their commitment to enhancing workflow efficiency through automation and rapid sequencing technologies makes them a key player in the future of genomic research. The demand for improved efficiency, precision, and accessibility in genomic studies underscores the importance of staying informed about developments in this field.